Reaction

Procalcitonin Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,139 reports · 47 co-occurring drugs

As of the last recalculation, Procalcitonin Increased appears in 1,139 FAERS reports alongside 47 co-occurring drug terms. The strongest observed disproportionality signal is MEROPENEM (PRR 44.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Meropenem	73	44.3	44.4
Polatuzumab Vedotin	22	42.0	42.1
Bendamustine Hcl	27	32.6	32.6
Dabrafenib	35	31.3	31.3
Piperacillin Sodium,Tazobactam Sodium	41	29.3	29.3
Cefepime Hydrochloride	25	29.0	29.0
Trametinib	37	28.9	28.9
Cefepime	22	28.6	28.6
Voriconazole Injection	30	25.9	25.9
Piperacillin And Tazobactam	16	23.2	23.2
Bendamustine Hydrochloride	14	21.6	21.6
Voriconazole	32	19.8	19.8
Blinatumomab	11	19.4	19.5
Vancomycin	56	18.6	18.6
Linezolid	28	17.6	17.6
Vancomycin Hydrochloride	60	17.5	17.5
Alemtuzumab	18	17.3	17.3
Ceftriaxone Sodium	34	16.7	16.7
Ceftriaxone	29	16.5	16.6
Piperacillin Sodium And Tazobactam Sodium	17	16.1	16.1
Gentamicin	11	15.5	15.5
Torsemide	27	15.2	15.2
Tranexamic Acid	7	14.5	14.5
Cytarabine	45	14.2	14.2
Vincristine Sulfate	22	14.0	14.0
Remdesivir	10	13.8	13.8
Norepinephrine Bitartrate	10	12.8	12.8
Febuxostat Tablets 40 Mg	7	12.7	12.7
Febuxostat Tablets 80 Mg	7	12.7	12.7
Imatinib	12	12.6	12.6
Norepinephrine	7	12.0	12.0
Pegaspargase	8	12.0	12.0
Valproic Acid	19	11.2	11.2
Sevoflurane	5	11.0	11.0
Amikacin	10	10.8	10.8
Obinutuzumab	9	10.1	10.1
Methoxy Polyethylene Glycol-Epoetin Beta	6	10.0	10.0
Axicabtagene Ciloleucel	5	9.3	9.3
Ticagrelor	16	9.3	9.3
Brentuximab Vedotin	5	8.9	9.0
Doxorubicin Hydrochloride	15	8.5	8.5
Ifosfamide	9	7.7	7.7
Iohexol	3	6.6	6.6
Pembrolizumab	36	6.4	6.4
Azacitidine For	6	6.1	6.1
Ethyl Alcohol	8	5.4	5.4
Palivizumab	3	3.6	3.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.